journal article·2025-12-24Open access

Dynamic Self-Assembly and Stimuli-Responsive Disassembly of Bioactive-Loaded Cubosomes in Biomimetic Media Traced by Real-Time Small-Angle X-ray Scattering and Cryogenic Transmission Electron Microscopy

Rafael R.M. Madrid, Angelina Angelova, Borislav Angelov, Gouranga Manna, Patrick D. Mathews, Omar Mertins

ACS Applied Materials & Interfaces· Volume 17· Issue 51

Abstract

High Resolution Image Download MS PowerPoint Slide Designing advanced functional materials capable of passing through complex biological environments requires a deep understanding of their dynamic structural behavior in situ . We investigate pH-responsive core–shell cubosomes for oral drug delivery applications. These nanoparticles comprise a lipid-based core of cubic Im3m liquid crystalline structure and are coated with a chitosan- N -arginine/alginate polyelectrolyte shell (PS). The cubosomes encapsulate varying concentrations (0–30% w/w) of Aloe vera -derived acemannan, an immunomodulatory macromolecular drug. Utilizing synchrotron small-angle X-ray scattering and cryogenic transmission electron microscopy, we performed an advanced spatiotemporal analysis, which focused on their nanoscale structural evolution under simulated gastric (pH 2.5) and intestinal (pH 7.4) conditions. The interactions with key individual gastrointestinal components, including mucins, pepsin, bile salts, and pancreatin, were systematically examined. Our results demonstrate that acemannan incorporation and environmental pH significantly modulate cubosome structure and heterogeneity (phase coexistence) during disassembly. The pH-responsive polyelectrolyte shell imparts notable structural stability against pepsin and mucins at pH 2.5, ensuring functional gastric protection. However, under intestinal conditions (pH 7.4), bile salt-mediated solubilization caused complete disassembly. Pancreatic lipase-induced digestion triggered a remarkable time-dependent phase transition from a cubic ( Im3m ) to an inverted hexagonal (H II ) topology in PS-cubosomes containing 30% acemannan. A simulated duodenum mixture induced lamellar phases at pH 2.5 for acemannan-loaded systems but led to complete disassembly at pH 7.4, primarily driven by bile salts. Deconvoluting these structural responses over time provides crucial insights into their mechanistic nature. It clarifies pH-dependent stability and component-specific disassembly pathways. The achieved understanding is crucial for designing advanced stimuli-responsive lipid/biopolymer nanomaterials that facilitate efficient oral delivery.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Lipid Membrane Structure and Behavior · Advancements in Transdermal Drug Delivery · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratory of NanoBioMaterials - LNBM, Department of Biophysics, Paulista Medical School

Federal University of Sao Paulo

Institut Galien Paris-Saclay, CNRS

Université Paris-Saclay

Department of Structural Dynamics

Extreme Light Infrastructure ERIC

ESRF, The European Synchrotron, 71 Avenue des Martyrs, Grenoble 38000, France

Institute of Bioscience

Sao Paulo State University

Funding

European Commission · European Regional Development Fund · Grantov? Agentura Cesk? Republiky · Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico · Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo · Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior

References (58)

Show source-provided references
1. 10.1038/nbt.333010.1038/nbt.3330 ↗
2. 10.1016/j.jcis.2024.05.08710.1016/j.jcis.2024.05.087 ↗
3. 10.1007/s12274-021-3595-510.1007/s12274-021-3595-5 ↗
4. 10.1016/j.jconrel.2009.01.00910.1016/j.jconrel.2009.01.009 ↗
5. 10.1002/adma.20060167910.1002/adma.200601679 ↗
6. 10.1039/C6RA26688F10.1039/C6RA26688F ↗
7. 10.1002/smll.20230920010.1002/smll.202309200 ↗
8. 10.1039/D2TB02670H10.1039/D2TB02670H ↗
9. 10.1002/anie.20180406710.1002/anie.201804067 ↗
10. 10.3390/biomedicines1104111410.3390/biomedicines11041114 ↗
11. 10.1016/j.jcis.2021.08.18710.1016/j.jcis.2021.08.187 ↗
12. 10.1016/j.jcis.2024.06.07310.1016/j.jcis.2024.06.073 ↗
13. 10.3390/IOCN2023-1448610.3390/IOCN2023-14486 ↗
14. 10.3390/nano1005096310.3390/nano10050963 ↗
15. 10.1021/acsbiomaterials.5c0000610.1021/acsbiomaterials.5c00006 ↗
16. 10.1021/acssuschemeng.1c0470610.1021/acssuschemeng.1c04706 ↗
17. 10.1016/j.molliq.2019.01.12410.1016/j.molliq.2019.01.124 ↗
18. 10.1016/j.colsurfb.2018.09.02310.1016/j.colsurfb.2018.09.023 ↗
19. 10.3390/molecules2710326310.3390/molecules27103263 ↗
20. 10.1021/acs.macromol.8b0060910.1021/acs.macromol.8b00609 ↗
21. 10.1016/j.bioadv.2023.21352510.1016/j.bioadv.2023.213525 ↗
22. 10.1021/acsami.5c1586310.1021/acsami.5c15863 ↗
23. 10.1021/acsami.5b0198410.1021/acsami.5b01984 ↗
24. 10.1016/j.cis.2019.10204510.1016/j.cis.2019.102045 ↗
25. 10.1016/j.jcis.2020.11.11010.1016/j.jcis.2020.11.110 ↗
26. 10.1002/jps.2432710.1002/jps.24327 ↗
27. 10.1039/C9SM01440C10.1039/C9SM01440C ↗
28. 10.1021/la101860410.1021/la1018604 ↗
29. 10.1021/jp021023y10.1021/jp021023y ↗
30. 10.1042/BST2021016810.1042/BST20210168 ↗
31. 10.1016/S1567-5769(01)00052-210.1016/S1567-5769(01)00052-2 ↗
32. 10.3390/gels907053910.3390/gels9070539 ↗
33. 10.1080/10408398.2018.149632010.1080/10408398.2018.1496320 ↗
34. 10.1021/nn501294610.1021/nn5012946 ↗
35. 10.1021/acsbiomaterials.1c0089010.1021/acsbiomaterials.1c00890 ↗
36. 10.1016/j.heliyon.2020.e0582010.1016/j.heliyon.2020.e05820 ↗
37. 10.1016/j.carbpol.2015.07.03910.1016/j.carbpol.2015.07.039 ↗
38. 10.1016/j.carbpol.2012.05.02910.1016/j.carbpol.2012.05.029 ↗
39. 10.3390/molecules2622679910.3390/molecules26226799 ↗
40. 10.1038/s41598-024-72233-110.1038/s41598-024-72233-1 ↗
41. 10.1038/nri.2016.8810.1038/nri.2016.88 ↗
42. 10.1073/pnas.112026910910.1073/pnas.1120269109 ↗
43. 10.1038/nrgastro.2013.3510.1038/nrgastro.2013.35 ↗
44. 10.1021/acs.jpcb.5b0707210.1021/acs.jpcb.5b07072 ↗
45. 10.1016/j.enzmictec.2020.10963210.1016/j.enzmictec.2020.109632 ↗
46. 10.1016/j.enzmictec.2021.10987110.1016/j.enzmictec.2021.109871 ↗
47. 10.1016/j.jcis.2017.04.05110.1016/j.jcis.2017.04.051 ↗
48. 10.1007/s11095-007-9304-610.1007/s11095-007-9304-6 ↗
49. 10.1016/j.ejpb.2018.07.00610.1016/j.ejpb.2018.07.006 ↗
50. 10.1021/acs.langmuir.8b0234310.1021/acs.langmuir.8b02343 ↗
51. 10.1021/acs.biochem.6b0099210.1021/acs.biochem.6b00992 ↗
52. 10.1111/eci.1216110.1111/eci.12161 ↗
53. 10.1007/s10620-006-9589-z10.1007/s10620-006-9589-z ↗
54. 10.1007/s13228-011-0015-410.1007/s13228-011-0015-4 ↗
55. 10.3390/polym1003026710.3390/polym10030267 ↗
56. 10.1016/j.ijbiomac.2020.01.16010.1016/j.ijbiomac.2020.01.160 ↗
57. 10.1016/S0006-3495(94)80632-010.1016/S0006-3495(94)80632-0 ↗
58. 10.1016/j.jcis.2022.10.11510.1016/j.jcis.2022.10.115 ↗